Results 81 to 90 of about 694 (158)

Recurrent local and systemic hypersensitivity reactions after switching back from subcutaneous to intravenous vedolizumab in ulcerative colitis: a case presentation. [PDF]

Gastroenterol Rep (Oxf)
Shibuya T, Ito K, Omori M, Odakura R, Koma M, Nomura K, Murakami T, Ueda K, Ishikawa D, Hojo M, Nagahara A.   +10 more
europepmc   +1 more source

Evaluation of Bilastine's Efficacy and Safety in Treating Chronic Idiopathic Urticaria in Iraqi Patients. [PDF]

Med J Islam Repub Iran
Abdul-Reda FS, Al-Zobaidy MAJ.
europepmc   +1 more source

Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes. [PDF]

J Allergy Clin Immunol Glob
Kobayashi Y, Nakagomi D, Hanai S, Tran NQV, Nakamura Y, Matsuoka T, Sakurai D, Nakao A.   +7 more
europepmc   +1 more source

In silico Evaluation of H1-Antihistamine as Potential Inhibitors of SARS-CoV-2 RNA-dependent RNA Polymerase: Repurposing Study of COVID-19 Therapy. [PDF]

Turk J Pharm Sci
Hamdan M, Kulabaş N, Küçükgüzel İ.
europepmc   +1 more source

An Unusual Case of Refractory Pemphigoid Gestationis with Neonatal Involvement: An Intricate Therapeutic Challenge. [PDF]

Indian Dermatol Online J
Çalıcıoğlu F, Avcı A, Tenk A, Tekin Y.   +3 more
europepmc   +1 more source

Allergic rhinitis and urticaria burden and antihistamine treatment options in Thailand: A modified Delphi study. [PDF]

J Allergy Clin Immunol Glob
Chantaphakul H, Chiewchalermsri C, Mairiang D, Lao-Araya M, Piboonpocanun O, Nanthapisal S, Mitthamsiri W, Kamchaisatian W, Manuyakorn W, Sangsupawanich P.   +9 more
europepmc   +1 more source

Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose.

Indian J Dermatol, 2023
De A, Shah B, Banodkar PD, Dhoot D, Chitnis K, Barkate H.   +5 more
europepmc   +1 more source

An Island Rash: A Case Study of Exercise-Induced Vasculitis. [PDF]

Cureus
Ferreira Veloso M, Alves da Silva C, Ferreira Vieira J.   +2 more
europepmc   +1 more source

Correction to: Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study. [PDF]

Indian J Otolaryngol Head Neck Surg
Singhal A, Agrawal P, Chatterji P, Matreja PS, Mahmood T.   +4 more
europepmc   +1 more source

Knowledge, Attitudes, and Practices of Dermatologists on Chronic Pruritus and Its Management. [PDF]

Cureus
Talwar A, Shivhare S, Joshi DK, Gala M, Muchhala SS, Bhagat SV, Sanghavi A, Katare S, Kotak BP.   +8 more
europepmc   +1 more source